Nordea har lavet en tidslinje for corona-vaccinernes godkendelse og distribution. Der er så mange farma-virksomheder igang og med så store produktionskapaciteter, at der bliver vacciner nok til alle.
Daily Corona update: A look at the vaccine timeline
The vaccine is coming. As its been a few weeks since Pfizer/BioNTech & Moderna released the late-stage vaccine results, we reflect on a possible vaccine timeline.
Chart of the day. Vaccine deployment timeline
The vaccine is coming. Pfizer said that an authorization is expected to be in place already during December (and they attend an FDA advisory committee meeting on the 10th of December in the US).
This would mean that the earliest deployment in the developed markets can happen in mid-late-december. Until production is entirely up to speed, the vaccine will likely only be given to high-risk groups, such as first responders, medical personal and nursing home workers, after which focus would shift towards other people that, given health characteristics, are also considered high-risk.
Now, admittedly, as we were running out of space the overview above only considers the amount of doses from Pfizer, Moderna and AstraZeneca since they are furthest in the process.
It is worth pointing out that other candidates are also in development. The Russian Sputnik V recently touted a 95% efficacy rate (similar to Pfizer/BioNTech and Moderna). Johnson & Johnson, will undoubtedly also be able to produce a massive amount once they have their results published and EUA approved.
Their late-stage trial data is expected to be released in January or February.
In other words, the pipeline is large and hope remains high that everyone (that wants to) can get vaccinated.
Chart 1. Change in case count per 100.000 people over the past 2 weeks
